Cited 0 time in
Free radical-scavenging and anti-amyloidogenic properties of chicoric acid
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | He, Mei Tong | - |
| dc.contributor.author | Cho, Eun Ju | - |
| dc.contributor.author | Kim, Ji-Hyun | - |
| dc.contributor.author | Kim, Hyun Young | - |
| dc.date.accessioned | 2026-01-07T07:00:10Z | - |
| dc.date.available | 2026-01-07T07:00:10Z | - |
| dc.date.issued | 2025-12 | - |
| dc.identifier.issn | 2468-0834 | - |
| dc.identifier.issn | 2468-0842 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/81630 | - |
| dc.description.abstract | Chicoric acid (CA) is a type of hydroxycinnamic acid that has been regarded as a functional ingredient given its health benefits for the treatment of Alzheimer’s disease (AD). In this study, free radical-scavenging capacities of CA were enhanced in a dose-dependent manner, after which the protective effects of CA against amyloid-beta (Aβ)-induced neurotoxicity in SH-SY5Y cells was investigated. CA suppressed Aβ25–35-induced increase in the production of reactive oxygen species. Stimulation with Aβ25–35 enhanced the protein expression of β-secretase and presenilin proteins, which were subsequently inhibited by CA. CA also affected the levels of low-density lipoprotein receptor-related protein-1 and receptor for advanced glycation endproducts, both of which are related to blood–brain barrier function. Furthermore, Aβ exposition downregulated insulin-degrading enzyme and neprilysin protein expressions, which were reversed by CA. Overall, the results suggest that CA may protect against Aβ-induced neurotoxicity via modulating Aβ generation and transportation. | - |
| dc.format.extent | 13 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 한국응용생명화학회 | - |
| dc.title | Free radical-scavenging and anti-amyloidogenic properties of chicoric acid | - |
| dc.title.alternative | Free radical-scavenging and antiamyloidogenic properties of chicoric acid | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.1186/s13765-025-01047-0 | - |
| dc.identifier.scopusid | 2-s2.0-105024483278 | - |
| dc.identifier.wosid | 001637686300002 | - |
| dc.identifier.bibliographicCitation | Applied Biological Chemistry, v.68, no.1, pp 1 - 13 | - |
| dc.citation.title | Applied Biological Chemistry | - |
| dc.citation.volume | 68 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 13 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART003273919 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Food Science & Technology | - |
| dc.relation.journalWebOfScienceCategory | Food Science & Technology | - |
| dc.subject.keywordPlus | INSULIN-DEGRADING ENZYME | - |
| dc.subject.keywordPlus | OXIDATIVE STRESS | - |
| dc.subject.keywordPlus | GAMMA-SECRETASE | - |
| dc.subject.keywordPlus | PHENOLIC EXTRACTS | - |
| dc.subject.keywordPlus | CELL-DEATH | - |
| dc.subject.keywordPlus | BETA | - |
| dc.subject.keywordPlus | BRAIN | - |
| dc.subject.keywordPlus | ANTIOXIDANT | - |
| dc.subject.keywordPlus | NEPRILYSIN | - |
| dc.subject.keywordPlus | MODEL | - |
| dc.subject.keywordAuthor | Amyloid-beta | - |
| dc.subject.keywordAuthor | Anti-amyloidogenic pathway | - |
| dc.subject.keywordAuthor | Blood brain barrier | - |
| dc.subject.keywordAuthor | Chicoric acid | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
